Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B …
SJ Schrag, JR Verani - Vaccine, 2013 - Elsevier
Abstract Group B Streptococcus (GBS) emerged as the leading cause of newborn infection
in the United States in the 1970s. In the 1980s clinical trials demonstrated that giving …
in the United States in the 1970s. In the 1980s clinical trials demonstrated that giving …
Group B streptococcal disease in infants: progress in prevention and continued challenges
JR Verani, SJ Schrag - Clinics in perinatology, 2010 - perinatology.theclinics.com
The burden of early onset neonatal sepsis due to group B Streptococcus (GBS) has declined
substantially over the past 20 years as a result of widespread use of intrapartum antibiotic …
substantially over the past 20 years as a result of widespread use of intrapartum antibiotic …
Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to
inform real-world use. Such studies are now underway amid the ongoing rollout of SARS …
inform real-world use. Such studies are now underway amid the ongoing rollout of SARS …
Association between mRNA vaccination and COVID-19 hospitalization and disease severity
Importance A comprehensive understanding of the benefits of COVID-19 vaccination
requires consideration of disease attenuation, determined as whether people who develop …
requires consideration of disease attenuation, determined as whether people who develop …
Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants
EK Accorsi, A Britton, KE Fleming-Dutra, ZR Smith… - Jama, 2022 - jamanetwork.com
Importance Assessing COVID-19 vaccine performance against the rapidly spreading SARS-
CoV-2 Omicron variant is critical to inform public health guidance. Objective To estimate the …
CoV-2 Omicron variant is critical to inform public health guidance. Objective To estimate the …
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective …
AS Lauring, MW Tenforde, JD Chappell, M Gaglani… - bmj, 2022 - bmj.com
Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …
[HTML][HTML] Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010
JR Verani, L McGee, SJ Schrag - 2010 - cdc.gov
Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease
since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the …
since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the …
[HTML][HTML] Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings
MG Thompson, E Stenehjem, S Grannis… - … England Journal of …, 2021 - Mass Medical Soc
Background There are limited data on the effectiveness of the vaccines against symptomatic
coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect …
coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect …
[HTML][HTML] First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
Summary Background Coronavirus disease 2019 (COVID-19) is a disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in …
[HTML][HTML] Effectiveness of mRNA Covid-19 vaccine among US health care personnel
T Pilishvili, R Gierke, KE Fleming-Dutra… - … England Journal of …, 2021 - Mass Medical Soc
Background The prioritization of US health care personnel for early receipt of messenger
RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS …
RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS …